Welcome to Artimmune - Your trusted partner in drug discovery for inflammation and infection. With a focus on scientific expertise, collaboration, and reliability, we are dedicated to advancing research in immunology and inflammation. As the world faces the challenges of COVID-19, Artimmune is committed to providing optimized research solutions. Our murine model of cytokine storm aids in the investigation of new drug candidates to combat COVID-19. Explore our preclinical CRO services and benefit from our extensive experience in lung diseases and immunology. Contact us to drive your research projects forward.
Our services
In vitro
In vitro studies are designed by Artimmune scientists to assess cellular toxicity and proof of concept of tested compounds, an essential step prior to animal and human studies. Our expertise and facilities (BSL1 and BSL2 laboratories) allow us to perform a study from conception and design to bench and analysis.
-
Primary cells culture
Bone-marrow derived Macrophages Dendritic cells Cell isolation T cells Fibroblasts Hepatocytes IELs Cell lines hAEC Human Airway Epithelial cells of bronchiolar origin NHBE Human primary bronchial Tracheal Epithelial cells hPBMC Human Peripheral Blood Mononuclear cells -
Cell lines
Mouse Raw 264.7 Macrophages Human A549 Epithelial cells Beas2B Bronchial epithelial cells SW-1116 Colon adenocarcinoma PL-45 Pancreatic carcinoma RKO Colon adenocarcinoma HPAF-II Pancreas adenocarcinoma BxPC-3 Pancreatic carcinoma PC-3 Prostate adenocarcinoma DU-145 Prostate carcinoma UM-UC-3 Urinary bladder carcinoma NCI-H292 Lung carcinoma Dog MDCK(NBL-2) Kidney DH82 Malignant histiocytosis